2,488
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer

, , , , , , & show all
Pages 1537-1548 | Received 17 Aug 2017, Accepted 27 Sep 2017, Published online: 10 Oct 2017

References

  • Akinc A, Thomas M, Klibanov AM, Langer R. (2005). Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7:657–63.
  • Aldawsari H, Edrada-Ebel R, Blatchford DR, et al. (2011). Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex. Biomaterials 32:5889–99.
  • Almalik A, Karimi S, Ouasti S, et al. (2013). Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles. Biomaterials 34:5369–80.
  • Arigita C, Zuidam NJ, Crommelin DJ, Hennink WE. (1999). Association and dissociation characteristics of polymer/DNA complexes used for gene delivery. Pharm Res 16:1534–41.
  • Behr J-P. (1997). The proton sponge: a trick to enter cells the viruses did not exploit. CHIMIA Int J Chem 51:34–6.
  • Chen W, Li H, Liu Z, Yuan W. (2016). Lipopolyplex for therapeutic gene delivery and its application for the treatment of Parkinson’s disease. Front Aging Neurosci 8:68.
  • Chiou CJ, Tseng LP, Deng MC, et al. (2009). Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials 30:5862–8.
  • Chollet P, Favrot MC, Hurbin A, Coll JL. (2002). Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 4:84–91.
  • Fischer D, Li Y, Ahlemeyer B, et al. (2003). In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121–31.
  • Godbey WT, Wu KK, Mikos AG. (1999). Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 45:268–75.
  • Haruyama K, Matsumura Y, Moriya Y, et al. (1999). Clinicopathological significance of the expression of CD44v2 in colorectal cancer. Anticancer Res 19:4421–8.
  • He Y, Cheng G, Xie L, et al. (2013). Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery. Biomaterials 34:1235–45.
  • Jeon O, Yang HS, Lee TJ, Kim BS. (2008). Heparin-conjugated polyethylenimine for gene delivery. J Control Release 132:236–42.
  • Jiang HL, Kim TH, Kim YK, et al. (2008). Efficient gene delivery using chitosan-polyethylenimine hybrid systems. Biomed Mater 3:025013.
  • Kalimutho M, Minutolo A, Grelli S, et al. (2011). Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells. Acta Pharmacol Sin 32:1387–96.
  • Koyama Y, Yamada E, Ito T, et al. (2002). Sugar‐containing polyanions as a self‐assembled coating of plasmid/polycation complexes for receptor‐mediated gene delivery. Macromol Biosci 2:251–6.
  • Kurosaki T, Kitahara T, Kawakami S, et al. (2009). The development of a gene vector electrostatically assembled with a polysaccharide capsule. Biomaterials 30:4427–34.
  • Lee H, Mok H, Lee S, et al. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release 119:245–52.
  • Li J, He Y, Sun W, et al. (2014). Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials 35:3666–77.
  • Lungwitz U, Breunig M, Blunk T, Gopferich A. (2005). Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60:247–66.
  • Margalit R, Okon M, Yerushalmi N, Avidor E. (1992). Bioadhesive liposomes as topical drug delivery systems: molecular and cellular studies. J Control Release 19:275–287.
  • Mironov V, Kasyanov V, Zheng Shu X, et al. (2005). Fabrication of tubular tissue constructs by centrifugal casting of cells suspended in an in situ crosslinkable hyaluronan-gelatin hydrogel. Biomaterials 26:7628–35.
  • Moghimi SM, Symonds P, Murray JC, et al. (2005). A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 11:990–5.
  • Neu M, Fischer D, Kissel T. (2005). Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7:992–1009.
  • Park JS, Yi SW, Kim HJ, Park KH. (2016). Receptor-mediated gene delivery into human mesenchymal stem cells using hyaluronic acid-shielded polyethylenimine/pDNA nanogels. Carbohydr Polym 136:791–802.
  • Sahiner N, Sagbas S, Sahiner M, Ayyala RS. (2017). Polyethyleneimine modified poly(Hyaluronic acid) particles with controllable antimicrobial and anticancer effects. Carbohydr Polym 159:29–38.
  • Schafer J, Hobel S, Bakowsky U, Aigner A. (2010). Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials 31:6892–900.
  • Seib FP, Jones AT, Duncan R. (2007). Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Control Release 117:291–300.
  • Siegel RL, Miller KD, Jemal A. (2017). Cancer Statistics, 2017. CA Cancer J Clin 67:7–30.
  • Thomas M, Klibanov AM. (2002). Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 99:14640–5.
  • Trubetskoy VS, Loomis A, Slattum PM, et al. (1999). Caged DNA does not aggregate in high ionic strength solutions. Bioconjugate Chem 10:624–8.
  • Underhill C. (1992). CD44: the hyaluronan receptor. J Cell Sci 103:293–8.
  • Wang LL, Guo HH, Zhan Y, et al. (2017). Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth. Oncotarget 8:25055–65.
  • Wang Y, Xu Z, Zhang R, et al. (2011). A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity. Colloids Surf B Biointerfaces 84:259–66.
  • Wang Z, Zhang Y, Gu JJ, et al. (2010). Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells. Int J Biochem Cell Biol 42:1030–8.
  • Wang Y, Zhu Y, Hu Q, Shen J. (2008). Construction of caged polyplexes with a reversible intracellular unpacking property to improve stability and transfection. Acta Biomater 4:1235–43.
  • Whitehead KA, Langer R, Anderson DG. (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8:129–38.
  • Xu P, Quick GK, Yeo Y. (2009). Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials 30:5834–43.
  • Yamamoto H, Takeuchi H, Hino T, Kawashima Y. (2000). Mucoadhesive liposomes: Physicochemical properties and release behavior of water-soluble drugs from chitosan-coated liposomes. Stp Pharma Sci 10:63–68.
  • Yerushalmi N, Arad A, Margalit R. (1994). Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophys 313:267–73.
  • Zalewski B, Famulski W, Sulkowska M, et al. (2001). CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features. Folia Histochem Cytobiol 39:152–3.
  • Zheng L, Wang L, Gan J, Zhang H. (2014). RNA activation: promise as a new weapon against cancer. Cancer Lett 355:18–24.